^
    No biomarker
    Merkel Cell Carcinoma
    avelumab
    Sensitive
    :
    A1
    No biomarker
    Merkel Cell Carcinoma
    pembrolizumab
    Sensitive
    :
    A1
    No biomarker
    Merkel Cell Carcinoma
    EP
    Sensitive
    :
    A2
    No biomarker
    Merkel Cell Carcinoma
    nivolumab
    Sensitive
    :
    A2
    No biomarker
    Merkel Cell Carcinoma
    cisplatin
    Sensitive
    :
    A2
    No biomarker
    Merkel Cell Carcinoma
    carboplatin
    Sensitive
    :
    A2
    No biomarker
    Merkel Cell Carcinoma
    carboplatin + etoposide oral
    Sensitive
    :
    A2
    No biomarker
    Merkel Cell Carcinoma
    topotecan
    Sensitive
    :
    A2
    No biomarker
    Merkel Cell Carcinoma
    AST-008
    Sensitive
    :
    B
    ARID2 mutation
    Merkel Cell Carcinoma
    Immunotherapy
    Sensitive
    :
    C3
    NTRK1 mutation
    Merkel Cell Carcinoma
    Immunotherapy
    Sensitive
    :
    C3
    PD-L1 expression
    Merkel Cell Carcinoma
    avelumab
    Sensitive
    :
    C3
    PD-1 expression
    Merkel Cell Carcinoma
    Immunotherapy
    Sensitive
    :
    C3
    DLL3 expression
    Merkel Cell Carcinoma
    rovalpituzumab tesirine
    Sensitive
    :
    C4
    NCAM1 expression
    Merkel Cell Carcinoma
    nivolumab
    Sensitive
    :
    C4
    TTF-1 expression
    Merkel Cell Carcinoma
    avelumab
    Sensitive
    :
    C4
    VERI is free for non-commercial use, no login needed.
    Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
    For commercial access, including additional premium features, please contact us.
    By using VERI, you are agreeing to our
    and
    Privacy Policy
    ACCEPT COOKIES